Skip to main content

CORRECTION article

Front. Microbiol., 21 October 2022
Sec. Infectious Agents and Disease
Volume 13 - 2022 | https://doi.org/10.3389/fmicb.2022.1059437

Corrigendum: Identification of novel therapeutic candidates against SARS-CoV-2 infections: An application of RNA sequencing toward mRNA based nanotherapeutics

This article is a correction to:

  1. Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics

    1. Read original article
\nZunera KhalidZunera Khalid1Ma HuanMa Huan1Muhammad Sohail Raza,,Muhammad Sohail Raza2,3,4Misbah AbbasMisbah Abbas5Zara NazZara Naz5Arnaud John Kombe KombeArnaud John Kombe Kombe5Weihong ZengWeihong Zeng5Hongliang HeHongliang He6Tengchuan Jin,, Tengchuan Jin1,5,7*
  • 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
  • 2CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China
  • 3China National Center for Bioinformation, Beijing, China
  • 4University of Chinese Academy of Sciences, Beijing, China
  • 5CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
  • 6Department of Infectious Diseases, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
  • 7CAS Center for Excellence in Molecular Cell Science, Shanghai, China

A corrigendum on
Identification of novel therapeutic candidates against SARS-CoV-2 infections: An application of RNA sequencing toward mRNA based nanotherapeutics

by Khalid, Z., Huan, M., Sohail Raza, M., Abbas, M., Naz, Z., Kombe Kombe, A. J., Zeng, W., He, H., and Jin, T. (2022). Front. Microbiol. 13:901848. doi: 10.3389/fmicb.2022.901848

In the published article, there was an error in affiliations 1, 5 and 6. Instead of “Division of Life Sciences and Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of University of Science and Technology of China (USTC), University of Science and Technology of China, Hefei, China,” it should be “Department of Obstetrics and Gynecology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.”

Instead of “CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine, School of Basic Medical Sciences, University of Science and Technology of China, Hefei, China,” it should be “CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.”

Instead of “Division of Life Sciences and Medicine, Department of Infectious Diseases, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China,” it should be “Department of Infectious Diseases, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SARS-CoV-2, PBMCs, RNA sequencing, upregulated genes, mRNA based nanotherapeutics, COVID-19 management

Citation: Khalid Z, Huan M, Sohail Raza M, Abbas M, Naz Z, Kombe Kombe AJ, Zeng W, He H and Jin T (2022) Corrigendum: Identification of novel therapeutic candidates against SARS-CoV-2 infections: An application of RNA sequencing toward mRNA based nanotherapeutics. Front. Microbiol. 13:1059437. doi: 10.3389/fmicb.2022.1059437

Received: 01 October 2022; Accepted: 03 October 2022;
Published: 21 October 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Khalid, Huan, Sohail Raza, Abbas, Naz, Kombe Kombe, Zeng, He and Jin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Tengchuan Jin, jint@ustc.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.